Schwazze Announces Management Changes to Schwazze Biosciences Ltd
May 11, 2021 at 04:00 pm IST
Share
Schwazze announced the launch of a wholly-owned research and development subsidiary, Schwazze Biosciences Ltd. Jeff Garwood, former CEO of GE Water & Process Technologies and current board member of Schwazze, will be the Chairman of the Management Board that includes Krishnamurthy and Jim Parco. Parco, Senior Vice President of Manufacturing for Schwazze, who holds a PhD in experimental economics, will head the new R&D entity as its inaugural President. Remy Kachadourian, who holds a PhD in chemistry, has also joined the newly formed subsidiary as the Director of Innovation and Quality.
Medicine Man Technologies, Inc., operating as Schwazze, is a vertically integrated multi-state cannabis operator. The Companyâs business involves the cultivation, manufacturing, distribution and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly owned retail stores, licensing arrangements, and/or third-party operators and retailers. It has three segments: Retail, Wholesale and Other. The Retail segment consists of retail locations for the sale of cannabis products. The Wholesale segment consists of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products. The Other segment encompasses the Companyâs general corporate operations, in-store advertisements and certain vendor promotions. It has operations in Colorado and New Mexico. The Company owns and operates 63 retail dispensaries, six cultivation facilities and three manufacturing facilities.
MEDICINE MAN TECHNOLOGIES, INC. 
